The Cerebellum

, Volume 9, Issue 4, pp 603–605 | Cite as

Depressive Mood is Associated with Ataxic and Non-Ataxic Neurological Dysfunction in SCA3 Patients

  • Jonas Alex Morales Saute
  • Andrew Chaves Feitosa da Silva
  • Karina Carvalho Donis
  • Leonardo Vedolin
  • Maria Luiza Saraiva-Pereira
  • Laura Bannach Jardim
Letter to the Editor

References

  1. 1.
    Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum. 2010. [Epub ahead of print]Google Scholar
  2. 2.
    Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.CrossRefPubMedGoogle Scholar
  3. 3.
    Schmitz-Hübsch T, Coudert M, Giunti P, Globas C, Baliko L, Fancellu R, et al. Self-rated health status in spinocerebellar ataxia—results from a European multicenter study. Mov Disord. 2010;5:587–95.Google Scholar
  4. 4.
    Cecchin CR, Pires AP, Rieder CR, Monte TL, Silveira I, Carvalho T, et al. Depressive symptoms in Machado–Joseph disease (SCA-3): patients and their relatives. Community Genet. 2007;10:19–26.CrossRefPubMedGoogle Scholar
  5. 5.
    Bauer PO, Kotliarova SE, Matoska V, Musova Z, Hedvicakova P, Boday A, et al. Fluorescent multiplex PCR—fast method for autosomal dominant spinocerebellar ataxias screening. Genetika. 2005;41:830–7.PubMedGoogle Scholar
  6. 6.
    Gorenstein C, Andrade L. Validation of a Portuguese version of the Beck Depression Inventory and the state–trait anxiety inventory in Brazilian subjects. Braz J Med Biol Res. 1996;29:453–7.PubMedGoogle Scholar
  7. 7.
    Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.CrossRefPubMedGoogle Scholar
  8. 8.
    Kieling C, Rieder CR, Silva AC, Saute JA, Cecchin CR, Monte TL, et al. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol. 2008;15:371–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Vedolin L, Schwartz IV, Komlos M, Schuch A, Azevedo AC, Vieira T, et al. Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology. 2007;69:917–24.CrossRefPubMedGoogle Scholar
  10. 10.
    Rüb U, Brunt ER, Deller T. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado–Joseph disease). Curr Opin Neurol. 2008;21:111–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Silva RCR, Saute JA, Silva ACF, Coutinho ACO, Saraiva-Pereira ML, Jardim LB. Occupational therapy in spinocerebellar ataxia type 3: an open-label trial. Braz J Med Biol Res. 2010 [Epub ahead of print]Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Jonas Alex Morales Saute
    • 1
    • 2
  • Andrew Chaves Feitosa da Silva
    • 3
  • Karina Carvalho Donis
    • 3
  • Leonardo Vedolin
    • 4
  • Maria Luiza Saraiva-Pereira
    • 3
  • Laura Bannach Jardim
    • 1
    • 3
    • 5
  1. 1.Postgraduate Program in Medical SciencesUniversidade Federal do Rio Grande do SulPorto AlegreBrazil
  2. 2.Neurology ServiceHospital de Clínicas de Porto AlegrePorto AlegreBrazil
  3. 3.Medical Genetics ServiceHospital de Clínicas de Porto AlegrePorto AlegreBrazil
  4. 4.Neuroradiology ServiceHospital Moinhos de VentoPorto AlegreBrazil
  5. 5.Department of Internal MedicineUniversidade Federal do Rio Grande do SulPorto AlegreBrazil

Personalised recommendations